X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (44) 44
humans (41) 41
index medicus (33) 33
cancer (25) 25
female (23) 23
male (19) 19
middle aged (19) 19
aged (18) 18
care and treatment (15) 15
chemotherapy (15) 15
pancreatic cancer (15) 15
prognosis (13) 13
adult (11) 11
aged, 80 and over (11) 11
survival (11) 11
medicine & public health (10) 10
treatment outcome (9) 9
animals (8) 8
clinical trials (8) 8
gemcitabine (8) 8
pharmacology & pharmacy (8) 8
radiotherapy (8) 8
dose-response relationship, drug (7) 7
patient outcomes (7) 7
surgery (7) 7
analysis (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
cancer research (6) 6
gastroenterology & hepatology (6) 6
health aspects (6) 6
immunotherapy (6) 6
management (6) 6
metastasis (6) 6
neoplasm staging (6) 6
neoplasms - drug therapy (6) 6
pancreatic neoplasms - drug therapy (6) 6
research (6) 6
tumors (6) 6
antineoplastic agents - therapeutic use (5) 5
article (5) 5
carcinoma (5) 5
diagnosis (5) 5
kaplan-meier estimate (5) 5
open-label (5) 5
patients (5) 5
therapy (5) 5
5-fluorouracil (4) 4
adenocarcinoma (4) 4
age factors (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - adverse effects (4) 4
cancer patients (4) 4
cetuximab (4) 4
expression (4) 4
metastases (4) 4
pancreatic neoplasms (4) 4
pancreatic neoplasms - pathology (4) 4
pancreatic-cancer (4) 4
pharmacology/toxicology (4) 4
retrospective studies (4) 4
survival analysis (4) 4
toxicity (4) 4
usage (4) 4
adjuvant (3) 3
adjuvant chemotherapy (3) 3
adolescent (3) 3
anderson cancer center (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
camptothecin - analogs & derivatives (3) 3
camptothecin - therapeutic use (3) 3
carcinoma, squamous cell - drug therapy (3) 3
cholangiocarcinoma (3) 3
clinical trials as topic (3) 3
cohort studies (3) 3
colorectal cancer (3) 3
confidence intervals (3) 3
crm1 (3) 3
disease-free survival (3) 3
enrollment (3) 3
experience (3) 3
fluorouracil - therapeutic use (3) 3
hematology (3) 3
human experimentation in medicine (3) 3
hydrazines - pharmacology (3) 3
immunology (3) 3
immunotherapy - methods (3) 3
inhibitors (3) 3
medical colleges (3) 3
medical prognosis (3) 3
medicine (3) 3
melanoma (3) 3
melanoma - pathology (3) 3
mice (3) 3
mitomycin (3) 3
neoplasm metastasis (3) 3
original reports (3) 3
pancreatic neoplasms - metabolism (3) 3
pancreatic neoplasms - surgery (3) 3
phase-ii (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2017, Volume 28, Issue suppl_3
Journal Article
Cancer Control, ISSN 1073-2748, 2014, Volume 21, Issue 3, pp. 188 - 189
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 4091 - 4091
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 672 - 672
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 399 - 399
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4_suppl, pp. 864 - 864
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 18, pp. 5339 - 5348
Purpose: Encorafenib, a selective BRAF inhibitor (BRAFi), has a pharmacologic profile that is distinct from that of other clinically active BRAFis. We... 
DABRAFENIB | IMPROVED SURVIVAL | MEK INHIBITION | ONCOLOGY | VEMURAFENIB | Humans | Male | Antineoplastic Agents - therapeutic use | Carbamates - administration & dosage | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Carbamates - pharmacokinetics | Antineoplastic Agents - adverse effects | Melanoma - genetics | Female | Antineoplastic Agents - pharmacokinetics | Drug Evaluation, Preclinical | Disease Models, Animal | Protein Kinase Inhibitors - pharmacokinetics | Kaplan-Meier Estimate | Treatment Outcome | Melanoma - pathology | Sulfonamides - pharmacokinetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Animals | Sulfonamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Sulfonamides - adverse effects | Carbamates - adverse effects | Mice | Mutation | Carbamates - therapeutic use | Drug Monitoring | Neoplasm Staging | Sulfonamides - administration & dosage | Melanoma - mortality | Toxicity | Melanoma | Nausea | Pharmacology | Metastasis | Myalgia | Patients | Anticancer properties | Metastases | Confidence intervals | Inhibitors | Experimental design | Safety engineering | Antitumor activity | Expansion | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2016, Volume 34, Issue 32, pp. 3838 - 3845
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e15241 - e15241
Journal Article
Investigational New Drugs, ISSN 0167-6997, 2018, Volume 37, Issue 3, pp. 473 - 481
Journal Article
Cancer Control, ISSN 1073-2748, 2014, Volume 21, Issue 3, pp. 209 - 214
Background: Despite the fact that cancer disproportionately affects the elderly, most participants of clinical cancer trials are relatively young. This... 
BREAST-CANCER | ENROLLMENT | IMPACT | MANAGEMENT | OLDER PATIENTS | ONCOLOGY | ADULTS | INCLUSION | CANCER-TREATMENT TRIALS | CHEMOTHERAPY TOXICITY | AGE | Age Factors | Humans | Patient Participation | Aged, 80 and over | Female | Male | Treatment Outcome | Aged | Clinical Trials as Topic - methods
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15799 - e15799
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 243 - 243
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 426 - 426
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 433 - 433
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e16118 - e16118
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.